E-LIB Suche - Ergebnisse für: Barve, Avantika

1

Efficacy and safety of ligelizumab in adults and adolescent..:

Maurer, Marcus ; Ensina, Luis Felipe ; Gimenez-Arnau, Ana Maria...
The Lancet. 403 (2024) 10422 - p. 147-159 , 2024

2

Efficacy and Safety of Ligelizumab in Chronic Spontaneous U..:

Ensina, Luis Felipe ; Bernstein, Jonathan ; Sussman, Gordon...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB130 , 2023

Link: https://doi.org/10.1016/..

3

Ligelizumab improves angioedema, disease severity and quali..:

Metz, Martin ; Bernstein, Jonathan A. ; Giménez-Arnau, Ana M....
World Allergy Organization Journal. 15 (2022) 11 - p. 100716 , 2022

Link: https://doi.org/10.1016/..

4

Sustained safety and efficacy of ligelizumab in patients wi..:

Maurer, Marcus ; Giménez‐Arnau, Ana ; Bernstein, Jonathan A....
Allergy. 77 (2021) 7 - p. 2175-2184 , 2021

Link: https://doi.org/10.1111/..

5

27362 High rate of complete response achieved with ligelizu..:

Bernstein, Jonathan A. ; Maurer, Marcus ; Giménez-Arnau, Ana...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB137 , 2021

Link: https://doi.org/10.1016/..

6

Long-term treatment with ligelizumab achieves prolonged sym..:

Soong, Weily ; Bernstein, Jonathan ; Sussman, Gordon...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB341 , 2020

Link: https://doi.org/10.1016/..

7

Drug‐Drug Interaction Studies With Oral Contraceptives: Pha..:

Sun, Haiying ; Sivasubramanian, Rama ; Vaidya, Soniya..
The Journal of Clinical Pharmacology. 60 (2020) S2 - p. , 2020

Link: https://doi.org/10.1002/..

8

Fevipiprant has a low risk of influencing co-medication pha..:

Poller, Birk ; Woessner, Ralph ; Barve, Avantika...
Pulmonary Pharmacology & Therapeutics. 57 (2019) - p. 101809 , 2019

Link: https://doi.org/10.1016/..

9

The Safety and Antiviral Activity of BZF961 with or without..:

Lawitz, Eric ; Bidair, Mohamed ; Marbury, Thomas...
Clinical Therapeutics. 40 (2018) 9 - p. 1567-1581.e4 , 2018

Link: https://doi.org/10.1016/..

10

Clinical Exposure Boost Predictions by Integrating Cytochro..:

Zhang, Jin ; Heimbach, Tycho ; Scheer, Nico...
Journal of Pharmaceutical Sciences. 105 (2016) 4 - p. 1398-1404 , 2016

Link: https://doi.org/10.1016/..

11

The effects of CYP3A4 induction and inhibition on the pharm..:

Barve, Avantika ; Kovacs, Steven J. ; Ke, June...
Clinical Pharmacology in Drug Development. 4 (2014) 1 - p. 25-32 , 2014

Link: https://doi.org/10.1002/..

12

Physiologically based pharmacokinetic modeling for assessin..:

Xia, Binfeng ; Barve, Avantika ; Heimbach, Tycho...
European Journal of Pharmaceutical Sciences. 63 (2014) - p. 103-112 , 2014

Link: https://doi.org/10.1016/..

13

Sa1031 Mild to Moderate Hepatic Impairment Has No Effect on..:

Kovacs, Steven J. ; Ke, June ; Praestgaard, Jens...
Gastroenterology. 144 (2013) 5 - p. S-977 , 2013

Link: https://doi.org/10.1016/..

14

Sa1081 Therapeutic Dose Effects of the Cyclophilin Inhibito..:

Kovacs, Steven J. ; Ke, June ; Dabovic, Kristina..
Gastroenterology. 142 (2012) 5 - p. S-964 , 2012

Link: https://doi.org/10.1016/..

15

γ‐Tocopherol‐enriched mixed tocopherol diet inhibits prosta..:

Barve, Avantika ; Khor, Tin Oo ; Nair, Sujit...
International Journal of Cancer. 124 (2009) 7 - p. 1693-1699 , 2009

Link: https://doi.org/10.1002/..